Welcome to OpenDEL™ Community A central hub to connect with global DEL professionals, access the latest industry insights and product updates, and collaborate to accelerate drug discovery. Learn More
DEL-Related Publications 24 April 2026 Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries Trevor A. Zandi, Michael J. Romanowski, Jessica S. Viscomi, Karl Gunderson, Zher Yin Tan, Bingqi Tong, Simone Bonazzi, Frédéric J. Zécri, Stuart L. Schreiber, Gregory A. Michaud Nature Communications DOI: 10.1038/s41467-026-71512-x Abstract Molecular glues are small molecules that engage their target and presenter proteins cooperatively. FKBP12 molecular glues (FK506 and rapamycin) were discovered several decades ago and have been used clinically, but our understanding of the breadth of FKBP12 molecular glues and targets has yet to be fully revealed. To expand the target classes of FKBP12 molecular glues, we construct and screen a multi-million-member non-macrocyclic FKBP12-ligand DNA-encoded library using 25 structurally distinct proteins. Synthesis and validation of select hits in biophysical and cell-based assays confirm FKBP12-dependent molecular-glue recruitment to bromodomain-containing protein 9 (BRD9) and quinoid dihydropteridine reductase (QDPR). One glue shows no measurable binding to QDPR alone but has appreciable binding in the presence of FKBP12 using either purified proteins or intact cells. The sites of recruitment are characterized with mutational analysis, competition-based methods and X-ray crystallography. The results of this study confirm that FKBP12-binding DELs can yield molecular glues generating highly selective FKBP12-target protein interactions. Learn More DEL Insights 23 April 2026 DEL Insight | HitGen Introduces CycWeave, a Token-Free Dual-View Graph Framework for Cyclic Peptidomimetics and DEL Modeling Overview Cyclic peptidomimetics (CPM) have attracted growing attention in drug discovery because they combine the developability of small molecules with the target-recognition capability of larger biomolecules. Yet their complex macrocyclic topologies, noncanonical amino acids, and diverse cross-linking chemistries continue to challenge conventional AI-based molecular modeling methods. Recently, the Computational Chemistry team at HitGen introduced CycWeave, a token-free dual-view coarse-grained graph neural framework designed for complex modular molecular systems. By adopting a representation strategy that better matches the modular nature of CPMs and DNA-encoded library (DEL) compounds, CycWeave demonstrated robust and competitive performance in both CPM membrane permeability prediction and large-scale DEL enrichment modeling. (Preprint available on ChemRxiv, https://chemrxiv.org/doi/full/10.26434/chemrxiv.15001512/v1) 01 Challenges in Current Computational Modeling In AI-driven drug discovery, computational modeling of CPMs and structurally complex DEL compounds faces two major limitations: 1. Atom-level graphs often fail to capture global topology Conventional graph neural networks (GNNs) primarily focus on local atoms and bonds, but often struggle to effectively represent the higher-order topological organization characteristic of cyclic peptide-like systems, such as scaffold architecture, branch placement, and connection patterns. 2. Vocabulary-dependent token models have limited generalization Many existing peptide or fragment-based modeling methods rely on predefined vocabularies or tokenization schemes. In realistic CPM-oriented DEL settings, however, noncanonical monomers and open-ended chemical modifications are common. As a result, such methods can suffer from out-of-vocabulary limitations and reduced generalizability in open chemical space. Figure 1. Summary of existing molecular modeling strategies for CPM 02 Core Design Logic of CycWeave To address these challenges, CycWeave introduces a new representation framework specifically designed for structurally complex and modular molecules. 1. Dual-view graph architecture CycWeave represents each molecule simultaneously as an atom-level graph and a fragment-level coarse-grained graph. The atom-level view captures local chemical environments, while the coarse-grained view explicitly preserves modular structure by decomposing molecules into scaffold, branch, and connection-level components, including key chemical relations such as amide linkages, ring connection sites, and disulfide bonds. The two views are coupled and fused within a unified neural architecture, enabling coordinated modeling of both local detail and global topology. 2. Token-free continuous fragment embeddings A central innovation of CycWeave is its token-free design. Instead of mapping fragments into discrete symbolic tokens, the framework uses continuous ECFP-based fragment embeddings to initialize coarse-grained nodes. This avoids dependence on a fixed vocabulary and enables the model to generalize more naturally to novel noncanonical monomers and open-ended chemical modifications. 3. Support for self-supervised pretraining CycWeave also supports a self-supervised pretraining–fine-tuning paradigm. Through a masked fragment recovery task, the model learns to reconstruct original continuous fragment fingerprints from surrounding structural context. This allows CycWeave to learn transferable structural priors from large unlabeled DEL-related CPM chemical spaces and improves its applicability to downstream tasks with limited labeled data. Figure 2. Schematic overview of the token-free coarse-grained dual-view framework of CycWeave. 03 Application Validation: Developability Assessment and DEL Screening Modeling The research team systematically evaluated CycWeave in two practically important application scenarios. 1. CPM membrane permeability prediction Membrane permeability is jointly influenced by local physicochemical features and higher-order structural organization. On public benchmark datasets including PAMPA, Caco-2, MDCK, and RRCK, CycWeave achieved the strongest overall performance on the major benchmarks after pretraining and fine-tuning. Notably, it reached an R² of 0.728 in Caco-2 and 0.701 on the aggregated dataset, outperforming representative intermediate-granularity baselines such as PepLand and PeptideCLM. These results support the value of token-free dual-view representation for developability-related property prediction. 2. DEL enrichment modeling against TfR1 The team further applied CycWeave to DEL enrichment modeling against transferrin receptor 1 (TfR1), a biologically and translationally relevant target in drug delivery research. Because DEL enrichment signals are count-derived and typically overdispersed, the model used a negative binomial negative log-likelihood loss rather than a simple mean squared error objective. Under 10-fold scaffold-split evaluation, CycWeave outperformed both the general-purpose graph learning baseline Chemprop and the classical ECFP-MLP baseline. It achieved R² = 0.596, AUC-ROC = 0.962, and AP = 0.764, demonstrating strong regression fit as well as effective prioritization of enriched compounds under class imbalance. In addition, latent-space visualization using t-SNE showed that enriched DEL compounds were organized into multiple separated yet internally compact clusters, suggesting that CycWeave not only improves predictive performance but may also help reveal distinct latent chemotypes or scaffold series for downstream hit triaging and series analysis. 04 Summary and Outlook The results of CycWeave suggest that, for complex modular molecular systems such as cyclic peptidomimetics and DEL compounds, chemically meaningful coarse-grained decomposition combined with a token-free open representation can substantially improve computational modeling performance. As a unified molecular representation backbone, CycWeave is expected to support not only CPM property prediction, but also a broader range of AI-for-chemistry applications, including DEL activity modeling, selectivity analysis, pharmacokinetic property prediction, and multi-objective molecular optimization. Learn More DEL-Related Publications 20 April 2026 Recent Advances in GPCR Ligand Discovery Using DNA-Encoded Library Technology: From Affinity Binding to Functional Bias and Allosteric Modulation Ruolan Zhou, Jiajia Wang, Xiang Li, Yulong An ACS Medicinal Chemistry Letters DOI: 10.1021/acsmedchemlett.6c00113 Abstract DNA-encoded library (DEL) technology has emerged as a transformative platform for the discovery of bioactive small molecules against challenging therapeutic targets including G protein-coupled receptors (GPCRs). As a clinically pivotal class of membrane-bound targets, GPCRs pose inherent challenges in the discovery of novel ligands. This Microperspective highlights recent methodological advances (2015–2026) that enable DEL selections against GPCRs, thereby facilitating the identification of diverse ligand modalities, including agonists, antagonists, allosteric modulators, and biased ligands. Furthermore, we discuss current challenges and future directions in the application of DEL technology to GPCR drug discovery, with a specific emphasis on opportunities in receptor stabilization, selection strategy design, and computational method development. Learn More DEL-Related Publications 20 April 2026 DNA-Encoded Libraries for the Discovery of E3 Ligase Ligands Lulu Wen,Qingqing Zhang,Zhiqiang Duan,Rui Jin,Xiaojie Lu ChemMedChem DOI: 10.1002/cmdc.202501032 Abstract DNA-encoded library (DEL) technology has emerged as a powerful tool to accelerate drug discovery, and its application has expanded to challenging targets such as E3 ubiquitin ligases, whose ligands are essential for the development of targeted therapies, including proteolysis-targeting chimeras (PROTACs). In this review, we summarize recent advances in the use of DELs for the discovery of small-molecule non-covalent E3 ligase ligands and discuss their advantages in hit-to-lead optimization and the design of targeted protein degradation systems. Furthermore, we highlight the potential and application basis of covalent DELs and DNA-encoded cyclic peptide libraries, which together outline promising future directions for DEL-based discovery of E3 ligase ligands. Emerging DEL-based strategies for the direct discovery and optimization of TPD molecules are also discussed. Learn More DEL-Related Publications 19 April 2026 Assessing the Generalizability of Machine Learning and Physics Methods for DNA-Encoded Libraries Marissa D Dolorfino, Daniel Santos Perez, Yao Fu, Shu-Hang Lin, Sean McCarty, Matthew James O'Meara, Terra Sztain bioRxiv - Biophysics DOI: 10.64898/2026.04.18.719394 Abstract DNA-encoded libraries (DELs) enable ultra-large screening of billions of molecules simultaneously. However, various limitations of DELs have prompted interest in training machine learning (ML) models on these large datasets to extrapolate predictions to non-DEL compounds. A recent NeurIPS competition revealed that even top performing ML models trained on DEL data failed at generalizing to out-of-distribution (OOD) chemical space. We investigated whether integrating structural modeling could bridge this generalization gap. We systematically assessed state-of-the-art ML, docking, and co-folding methods with three biologically diverse protein targets screened against libraries containing multiple DEL synthesis formats, and show that while ML excels in-distribution, the optimal approach for OOD hit discrimination performance is both target and ligand dependent. We conclude that, regardless of performance reported in aggregated benchmarks, rigorous, system-dependent pilot testing is critical for reliable virtual screening predictions. We provide these workflows and analysis tools in an open-source package: DEL-iver. Learn More DEL-Related Publications 10 April 2026 Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeability J. Miguel Mata, Jingming Liu, Sean M. McKenna, Edith van der Nol, Marije Havermans, Ruud Delwel, Mike Filius, Chirlmin Joo, Maura Vallaro, Giulia Caron, Sebastian J. Pomplun Nature Communications DOI: 10.1038/s41467-026-71641-3 Abstract Synthetic macrocycles offer exceptional potential as therapeutics. However, most high-throughput discovery platforms rely on genetically encoded libraries of large peptide macrocycles, which typically are not optimized for drug like properties. Fully synthetic libraries offer greater flexibility in accessing broader chemical space. Leveraging recent advances in mass spectrometry based library techniques, here we report CycloSEL (Cyclic Self-Encoded Libraries), an end-to-end workflow, that screens synthetic macrocycle libraries enriched in drug-like ‘beyond rule of five’ features. The workflow relies on affinity selections and hit identification by tandem mass spectrometry, eliminating the need for genetic barcodes. We construct a 16 million-member library and validate the approach against the oncology target carbonic anhydrase IX, achieving robust enrichment and accurate identification of true binders. Applying CycloSEL to the acute myeloid leukemia target WD repeat-containing protein 5 (WDR5) yields a macrocycle with subnamolar affinity, and potent inhibition of the WDR5–Mixed-Lineage Leukemia 1 (MLL1) interaction. Subsequent modifications produce a chameleonic macrocycle with passive membrane permeability, serum stability, and anti-proliferative activity in leukemia cells. Together, these results demonstrate that CycloSEL enables discovery of drug-like macrocycles from fully synthetic libraries for intracellular targets. Learn More
OpenDEL™ - Small Molecule Starting Your Journey to Access the Vast Chemical Space The Kit 57 Libraries ~3.8Bn compounds 10 DEL samples To Access Fully Enumerated Molecules Building Block Structures DNA Codon Sequences Scaffolds Information ✔ No Structure Disclosure Fee ✔ No Compound IP License Fee
OpenDEL™ Screening OpenDEL™ screening is carried out by our team of experienced professionals, proficient in handling over 50 different target types including protein-protein interactions, kinases, enzymes, transcription factors, and RNA targets. Our team typically completes the screening experiments within 1-2 weeks.
OpenDEL™ Sequencing HitGen offers high-quality and gold sequencing service includes. Global Sample Shipment Outstanding Sequencing Quality Lightning-speed Result Delivery Diverse Sequencing Options
OpenDEL™ Hit Proposal Analyzing DEL selection data and choosing the right compounds for follow-up necessitates multidisciplinary expertise encompassing biology, computational science, and chemistry. This includes a deep understanding of the experimental design and mechanisms of action (MOAs) in biology, data processing and analysis in computational science, and aspects of both synthetic and DEL chemistry
OpenDEL™ Off-DNA Synthesis HitGen Chemical Services: Innovation-Driven and Precision-Empowered. We transform your DEL hits into tangible results by delivering the pure, complex structures critical for validating discoveries and accelerating their advancement. Choose Your Path: A. Traditional Chemical Synthesis @ HitGen B. High Throughput Chemical Synthesis @ HitGen